(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

DREAMED ADVISOR

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: Estados Unidos

Snapshot rápido

DREAMED ADVISOR

ST13

US500000079267061

Classe

9, 10, 44

Pedido

79267061

Registro

6055694

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

40

Atualização mais recente

20/05/2025

Tipo de marca

Verbal

Classes Nice

9, 10, 44

Data de depósito

17/06/2019

Data de registro

19/05/2020

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

19/05/2020

Última transação

20/05/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

16

Localização do titular

4952701 Petah Tikva, IL

Examinador

SPARROW,MARY

Unidade examinadora

L60

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

DreaMed Diabetes LTD.

Representantes

Alex Patel Patel & Almeida PC

Classificação técnica

Classes Nice

Classe 9Classe 10Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Ddownloadable software for analysis of medical information in the field of diabetes

Classe 10

Wearable medical apparatus for the monitoring and compilation of medical information in the field of diabetes; medical apparatus inserted into the human body for the monitoring and compilation of medical information in the field of diabetes; medical apparatus for the compilation of medical information and medical specimens from patients in the field of diabetes

Classe 44

Medical analysis for the treatment of persons; providing information in the field of medicine; providing information to patients in the field of administering medication; consultancy for medical purposes; medical analysis services relating to the treatment of patients; medical analysis services relating to the treatment of persons; medical care and analysis services relating to patient treatment; medical services in the field of diabetes; providing information via the Internet in the field of diabetes; advisory services relating to healthcare; advisory services relating to health

Publicações

Histórico de despachos e eventos da marca no USPTO.

40 publicações encontradas

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

19/05/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

14/04/2023

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

14/04/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

14/04/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

14/04/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/10/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

17/09/2020

FIMP

FINAL DISPOSITION PROCESSED

17/09/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

19/08/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

19/05/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/03/2020

PUBO

PUBLISHED FOR OPPOSITION

03/03/2020

GPNX

NOTIFICATION PROCESSED BY IB

28/02/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/02/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

12/02/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/02/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

24/01/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

23/01/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

23/01/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

23/01/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

23/01/2020

DOCK

ASSIGNED TO EXAMINER

22/01/2020

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

22/01/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

14/01/2020

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

31/12/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

25/12/2019

ALIE

ASSIGNED TO LIE

11/12/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/12/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

27/11/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

26/11/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

26/11/2019

RFNT

REFUSAL PROCESSED BY IB

12/10/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

26/09/2019

RFRR

REFUSAL PROCESSED BY MPU

26/09/2019

MAFR

APPLICATION FILING RECEIPT MAILED

20/09/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

18/09/2019

CNRT

NON-FINAL ACTION WRITTEN

17/09/2019

DOCK

ASSIGNED TO EXAMINER

16/09/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

16/09/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/09/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace DREAMED ADVISOR ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.